Bodick Neil

Chief Scientific Officer at Flexion Therapeutics Inc

Sold, on record
$2.4M
Dollars the filings state
Form 4 sales
13
Latest Jan 3, 2020
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Flexion Therapeutics IncPlan not stated
    Jan 20, 2017 2017

    Sold 5,000 shares at $18.35 ($92k)

    Bodick Neil, Chief Medical Officer

    Sold 7.6% of holdings ($1.2M position)60,937 shares left1.3x usual sizeFiling

  2. 2 Form 4 sale Flexion Therapeutics IncPlan not stated
    Feb 24, 2017 +35 days

    Sold 5,000 shares at $19.15 ($96k)

    Bodick Neil, Chief Medical Officer

    Sold 8.2% of holdings ($1.2M position)55,937 shares left1.3x usual sizeFiling

  3. 3 Form 4 sale Flexion Therapeutics IncPlan not stated
    Mar 17, 2017 +21 days

    Sold 5,000 shares at $20.41 ($102k)

    Bodick Neil, Chief Medical Officer

    Sold 8.9% of holdings ($1.1M position)50,937 shares left1x usual sizeFiling

  4. 4 Form 4 sale Flexion Therapeutics IncPlan not stated
    Apr 17, 2017 +31 days

    Sold 5,000 shares at $28.23 ($141k)

    Bodick Neil, Chief Medical Officer

    Sold 9.8% of holdings ($1.4M position)45,937 shares left1x usual sizeFiling

  5. 5 Form 4 sale Flexion Therapeutics IncPlan not stated
    May 15, 2017 +28 days

    Sold 6,830 shares at $18.95 ($129k)

    Bodick Neil, Chief Medical Officer

    Sold 14.9% of holdings ($871k position)39,107 shares left1.4x usual sizeFiling

  6. 6 Form 4 sale Flexion Therapeutics IncUnusual
    Jul 3, 2018 +414 days

    Sold 50,000 shares at $25.07 ($1.3M)

    Bodick Neil, Chief Scientific Officer

    Sold 44.5% of holdings ($2.8M position)62,307 shares left10x usual sizeFiling

  7. 7 Form 4 sale Flexion Therapeutics IncPlan not stated
    Jan 3, 2019 +184 days

    Sold 746 shares at $12.36 ($9k)

    Bodick Neil, Chief Scientific Officer

    Sold 1.1% of holdings ($810k position)64,782 shares left0.1x usual sizeFiling

  8. 8 Form 4 sale Flexion Therapeutics IncPlan not stated
    Jan 3, 2020 +365 days

    Sold 3,851 shares

    Bodick Neil, Chief Scientific Officer

    Sold 3.7% of holdings100,153 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Bodick Neil
Source
Jan 3, 2020Jan 7, 2020Flexion Therapeutics IncChief Scientific OfficerForm 4 sale3,8513.7%Plan not statedSEC
Jan 3, 2019Jan 4, 2019Flexion Therapeutics IncChief Scientific OfficerForm 4 sale746$9k1.1%Plan not statedSEC
Jul 3, 2018Jul 3, 2018Flexion Therapeutics IncChief Scientific OfficerForm 4 sale50,000$1.3M44.5%UnusualSEC
May 15, 2017May 17, 2017Flexion Therapeutics IncChief Medical OfficerForm 4 sale6,830$129k14.9%Plan not statedSEC
Apr 17, 2017Apr 18, 2017Flexion Therapeutics IncChief Medical OfficerForm 4 sale5,000$141k9.8%Plan not statedSEC
Mar 17, 2017Mar 20, 2017Flexion Therapeutics IncChief Medical OfficerForm 4 sale5,000$102k8.9%Plan not statedSEC
Feb 24, 2017Feb 27, 2017Flexion Therapeutics IncChief Medical OfficerForm 4 sale5,000$96k8.2%Plan not statedSEC
Jan 20, 2017Jan 23, 2017Flexion Therapeutics IncChief Medical OfficerForm 4 sale5,000$92k7.6%Plan not statedSEC
Dec 21, 2016Dec 22, 2016Flexion Therapeutics IncChief Medical OfficerForm 4 sale10,000$185k13.2%Plan not statedSEC
Mar 16, 2015Mar 16, 2015Flexion Therapeutics IncChief Medical OfficerForm 4 sale4,000$101k5.3%Plan not statedSEC
Mar 10, 2015Mar 11, 2015Flexion Therapeutics IncChief Medical OfficerForm 4 sale4,000$97k5.1%Plan not statedSEC
Mar 4, 2015Mar 5, 2015Flexion Therapeutics IncChief Medical OfficerForm 4 sale4,000$94k4.8%Plan not statedSEC
Feb 26, 2015Feb 26, 2015Flexion Therapeutics IncChief Medical OfficerForm 4 sale4,000$90k4.6%Plan not statedSEC